Statsure Diagnostic Systems, Inc. - Current report filing (8-K)
09 11월 2007 - 1:58AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the
Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported): October 22, 2007
StatSure
Diagnostic Systems, Inc.
(Exact
name of Registrant as specified in its charter)
(State
or
other jurisdiction of incorporation)
|
|
|
|
|
000-21284
|
|
|
|
91-1549305
|
(Commission
|
|
|
|
(IRS
Employer
|
File
Number)
|
|
|
|
Identification
No.)
|
|
|
|
|
|
1881
Worcester Rd. #200, Framingham, MA.
|
|
01701
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
508.872.2625
(Registrant’s
telephone number, including area code)
Saliva
Diagnostic Systems, Inc.
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM
7.01. Regulation FD Disclosures.
On
November 5, 2007, the Company issued the press release titled “
StatSure's
Patented HIV 'Barrel' Technology Receives CLIA Waiver From
FDA
”
included herein as Exhibit 99.1.
In
accordance with General Instruction B.2 of Form 8-K, the information in this
Current Report on Form 8-K shall not be deemed “filed” for the purpose of
Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed
incorporated by reference in any filing. This Current Report on Form 8-K does
not constitute a determination of whether any information included herein is
material.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Saliva
Diagnostic Systems, Inc.
|
Date:
November
8, 2007
|
By:
|
/s/
Steven Peltzman
|
|
|
Steven
Peltzman
|
|
|
Chief
Executive Officer
|
StatSure Diagnostic Syst... (CE) (USOTC:SSUR)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
StatSure Diagnostic Syst... (CE) (USOTC:SSUR)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
StatSure Diagnostic Systems Inc (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Statsure Diagnostic Systems, Inc. News Articles